Sunshine Biopharma Targets Multidrug-Resistant Cancer
By Marie Powers
Friday, October 21, 2011
Canadian biotech Sunshine Biopharma Inc. is seeking to bring a ray of light to women with multidrug-resistant breast cancer by arresting the rapid development and spread of their disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.